NasdaqGS - Nasdaq Real Time Price USD

Embecta Corp. (EMBC)

12.50
+0.09
+(0.73%)
At close: 4:00:02 PM EDT
12.50
0.00
(0.00%)
After hours: 4:20:00 PM EDT
Loading Chart for EMBC
  • Previous Close 12.41
  • Open 12.35
  • Bid 12.45 x 100
  • Ask 12.53 x 200
  • Day's Range 12.12 - 12.71
  • 52 Week Range 10.83 - 21.48
  • Volume 486,147
  • Avg. Volume 604,930
  • Market Cap (intraday) 730.531M
  • Beta (5Y Monthly) 1.19
  • PE Ratio (TTM) 14.04
  • EPS (TTM) 0.89
  • Earnings Date Aug 7, 2025 - Aug 11, 2025
  • Forward Dividend & Yield 0.60 (4.51%)
  • Ex-Dividend Date Feb 28, 2025
  • 1y Target Est 19.75

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

www.embecta.com

2,100

Full Time Employees

September 30

Fiscal Year Ends

Recent News: EMBC

View More

Performance Overview: EMBC

Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

EMBC
38.78%
S&P 500 (^GSPC)
0.08%

1-Year Return

EMBC
8.15%
S&P 500 (^GSPC)
12.74%

3-Year Return

EMBC
48.12%
S&P 500 (^GSPC)
46.29%

5-Year Return

EMBC
73.96%
S&P 500 (^GSPC)
108.74%

Compare To: EMBC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EMBC

View More

Valuation Measures

Annual
As of 5/12/2025
  • Market Cap

    725.27M

  • Enterprise Value

    2.07B

  • Trailing P/E

    13.94

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.67

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.92

  • Enterprise Value/EBITDA

    9.99

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.25%

  • Return on Assets (ttm)

    3.13%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.11B

  • Net Income Avi to Common (ttm)

    58.2M

  • Diluted EPS (ttm)

    0.89

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    210M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -37.41M

Research Analysis: EMBC

View More

Company Insights: EMBC

Research Reports: EMBC

View More

People Also Watch